IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KRISTI LEBESCO

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1386279172
CMS profile
11035209
Location
DANA POINT, CA

General Payments · PY2022–2024

$2,668.26

  • Reported across 114 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,231.87

51 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatric/Mental Health CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,204.60 50
Education $27.27 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $292.52 11
Janssen Pharmaceuticals, Inc $147.18 1
Otsuka America Pharmaceutical, Inc. $144.40 9
Alkermes, Inc. $136.03 8
E.R. Squibb & Sons, L.L.C. $134.61 5
ABBVIE INC. $134.31 7
Axsome Therapeutics, Inc. $78.46 4
Almatica Pharma Inc. $63.21 2
Teva Pharmaceuticals USA, Inc. $41.93 2
Vanda Pharmaceuticals Inc. $38.88 1
Neurocrine BioSciences, Inc. $20.34 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $264.70 5
PY2023 $1,171.69 58
PY2024 $1,231.87 51

Payment records · PY2024 (51)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.09 02/27/2024 Food and Beverage Undisputed 01/23/2026 1107519219 CMS
ABBVIE INC. $20.71 04/29/2024 Food and Beverage Undisputed 01/23/2026 1107519221 CMS
ABBVIE INC. $34.74 06/10/2024 Food and Beverage Undisputed 01/23/2026 1107519223 CMS
ABBVIE INC. $10.60 07/26/2024 Food and Beverage Undisputed 01/23/2026 1107519225 CMS
ABBVIE INC. $22.09 10/02/2024 Food and Beverage Undisputed 01/23/2026 1107519227 CMS
ABBVIE INC. $9.84 10/29/2024 Food and Beverage Undisputed 01/23/2026 1107519229 CMS
ABBVIE INC. $20.24 11/15/2024 Food and Beverage Undisputed 01/23/2026 1107519231 CMS
Alkermes, Inc. $4.84 04/01/2024 Food and Beverage Undisputed 01/23/2026 1120539959 CMS
Alkermes, Inc. $18.82 04/16/2024 Food and Beverage Undisputed 01/23/2026 1120539961 CMS
Alkermes, Inc. $17.08 06/04/2024 Food and Beverage Undisputed 01/23/2026 1120539963 CMS
Alkermes, Inc. $7.28 07/02/2024 Food and Beverage Undisputed 01/23/2026 1120539965 CMS
Alkermes, Inc. $27.83 08/14/2024 Food and Beverage Undisputed 01/23/2026 1120539967 CMS
Alkermes, Inc. $20.55 09/10/2024 Food and Beverage Undisputed 01/23/2026 1120539969 CMS
Alkermes, Inc. $20.90 10/22/2024 Food and Beverage Undisputed 01/23/2026 1120539971 CMS
Alkermes, Inc. $18.73 12/03/2024 Food and Beverage Undisputed 01/23/2026 1120539973 CMS
Almatica Pharma LLC $31.84 05/29/2024 Food and Beverage Undisputed 01/23/2026 1137604132 CMS
Almatica Pharma LLC $31.37 06/12/2024 Food and Beverage Undisputed 01/23/2026 1137604136 CMS
Axsome Therapeutics, Inc. $21.10 01/08/2024 Food and Beverage Undisputed 01/23/2026 1148380406 CMS
Axsome Therapeutics, Inc. $21.23 01/23/2024 Food and Beverage Undisputed 01/23/2026 1148380408 CMS
Axsome Therapeutics, Inc. $15.23 04/15/2024 Food and Beverage Undisputed 01/23/2026 1148380410 CMS
Axsome Therapeutics, Inc. $20.90 05/14/2024 Food and Beverage Undisputed 01/23/2026 1148380412 CMS
E.R. Squibb & Sons, L.L.C. $23.19 08/22/2024 Food and Beverage Undisputed 01/23/2026 1101382586 CMS
E.R. Squibb & Sons, L.L.C. $27.27 10/03/2024 Education Undisputed 01/23/2026 1101382596 CMS
E.R. Squibb & Sons, L.L.C. $22.18 10/03/2024 Food and Beverage Undisputed 01/23/2026 1101382600 CMS
E.R. Squibb & Sons, L.L.C. $31.26 11/04/2024 Food and Beverage Undisputed 01/23/2026 1101382606 CMS
E.R. Squibb & Sons, L.L.C. $30.71 12/17/2024 Food and Beverage Undisputed 01/23/2026 1101382624 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.01 04/06/2024 Food and Beverage Undisputed 01/23/2026 1143532179 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $129.45 04/18/2024 Food and Beverage Undisputed 01/23/2026 1143532181 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $30.90 08/08/2024 Food and Beverage Undisputed 01/23/2026 1143532183 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.80 08/23/2024 Food and Beverage Undisputed 01/23/2026 1143532185 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $27.24 09/30/2024 Food and Beverage Undisputed 01/23/2026 1143532187 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.73 10/11/2024 Food and Beverage Undisputed 01/23/2026 1143532189 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $10.37 10/24/2024 Food and Beverage Undisputed 01/23/2026 1143532191 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $11.37 11/01/2024 Food and Beverage Undisputed 01/23/2026 1143532193 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.39 11/16/2024 Food and Beverage Undisputed 01/23/2026 1143532195 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $10.74 11/26/2024 Food and Beverage Undisputed 01/23/2026 1143532197 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.52 12/11/2024 Food and Beverage Undisputed 01/23/2026 1143532199 CMS
Janssen Pharmaceuticals, Inc $147.18 11/21/2024 Food and Beverage Undisputed 01/23/2026 1077922853 CMS
Neurocrine Biosciences, Inc. $20.34 05/02/2024 Food and Beverage Undisputed 01/23/2026 1150978136 CMS
Otsuka America Pharmaceutical, Inc. $7.78 01/09/2024 Food and Beverage Undisputed 01/23/2026 1119120278 CMS
Otsuka America Pharmaceutical, Inc. $4.45 01/09/2024 Food and Beverage Undisputed 01/23/2026 1119120280 CMS
Otsuka America Pharmaceutical, Inc. $19.42 02/22/2024 Food and Beverage Undisputed 01/23/2026 1119120282 CMS
Otsuka America Pharmaceutical, Inc. $2.26 02/22/2024 Food and Beverage Undisputed 01/23/2026 1119120284 CMS
Otsuka America Pharmaceutical, Inc. $21.50 04/04/2024 Food and Beverage Undisputed 01/23/2026 1119120286 CMS
Otsuka America Pharmaceutical, Inc. $26.95 07/26/2024 Food and Beverage Undisputed 01/23/2026 1119120288 CMS
Otsuka America Pharmaceutical, Inc. $17.39 08/28/2024 Food and Beverage Undisputed 01/23/2026 1119120290 CMS
Otsuka America Pharmaceutical, Inc. $20.60 09/17/2024 Food and Beverage Undisputed 01/23/2026 1119120292 CMS
Otsuka America Pharmaceutical, Inc. $24.05 12/02/2024 Food and Beverage Undisputed 01/23/2026 1119120294 CMS
Teva Pharmaceuticals USA, Inc. $17.93 01/29/2024 Food and Beverage Undisputed 01/23/2026 1151452707 CMS
Teva Pharmaceuticals USA, Inc. $24.00 06/03/2024 Food and Beverage Undisputed 01/23/2026 1151452779 CMS
Vanda Pharmaceuticals Inc. $38.88 09/21/2024 Food and Beverage Undisputed 01/23/2026 1133953826 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.